MedCap AB (Sweden) Market Value
| MCAP Stock | SEK 551.00 3.00 0.55% |
| Symbol | MedCap |
MedCap AB 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MedCap AB's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MedCap AB.
| 06/09/2023 |
| 11/30/2024 |
If you would invest 0.00 in MedCap AB on June 9, 2023 and sell it all today you would earn a total of 0.00 from holding MedCap AB or generate 0.0% return on investment in MedCap AB over 540 days. MedCap AB is related to or competes with Biotage AB, Invisio Communications, Vitrolife, AddLife AB, and CellaVision. MedCap AB is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation,... More
MedCap AB Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MedCap AB's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MedCap AB upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.39 | |||
| Information Ratio | (0.0008) | |||
| Maximum Drawdown | 11.61 | |||
| Value At Risk | (4.20) | |||
| Potential Upside | 4.34 |
MedCap AB Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for MedCap AB's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MedCap AB's standard deviation. In reality, there are many statistical measures that can use MedCap AB historical prices to predict the future MedCap AB's volatility.| Risk Adjusted Performance | 0.0486 | |||
| Jensen Alpha | 0.1495 | |||
| Total Risk Alpha | (0.29) | |||
| Sortino Ratio | (0.0008) | |||
| Treynor Ratio | (0.67) |
MedCap AB Backtested Returns
Currently, MedCap AB is very steady. MedCap AB has Sharpe Ratio of 0.0546, which conveys that the firm had a 0.0546% return per unit of risk over the last 3 months. We have found thirty technical indicators for MedCap AB, which you can use to evaluate the volatility of the firm. Please verify MedCap AB's Downside Deviation of 2.39, risk adjusted performance of 0.0486, and Mean Deviation of 1.98 to check out if the risk estimate we provide is consistent with the expected return of 0.14%. MedCap AB has a performance score of 4 on a scale of 0 to 100. The company secures a Beta (Market Risk) of -0.19, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning MedCap AB are expected to decrease at a much lower rate. During the bear market, MedCap AB is likely to outperform the market. MedCap AB right now secures a risk of 2.49%. Please verify MedCap AB semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and standard deviation , to decide if MedCap AB will be following its current price movements.
Auto-correlation | 0.29 |
Poor predictability
MedCap AB has poor predictability. Overlapping area represents the amount of predictability between MedCap AB time series from 9th of June 2023 to 5th of March 2024 and 5th of March 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MedCap AB price movement. The serial correlation of 0.29 indicates that nearly 29.0% of current MedCap AB price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.29 | |
| Spearman Rank Test | 0.32 | |
| Residual Average | 0.0 | |
| Price Variance | 3592.69 |
MedCap AB lagged returns against current returns
Autocorrelation, which is MedCap AB stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting MedCap AB's stock expected returns. We can calculate the autocorrelation of MedCap AB returns to help us make a trade decision. For example, suppose you find that MedCap AB has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
MedCap AB regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If MedCap AB stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if MedCap AB stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in MedCap AB stock over time.
Current vs Lagged Prices |
| Timeline |
MedCap AB Lagged Returns
When evaluating MedCap AB's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of MedCap AB stock have on its future price. MedCap AB autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, MedCap AB autocorrelation shows the relationship between MedCap AB stock current value and its past values and can show if there is a momentum factor associated with investing in MedCap AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MedCap Stock Analysis
When running MedCap AB's price analysis, check to measure MedCap AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedCap AB is operating at the current time. Most of MedCap AB's value examination focuses on studying past and present price action to predict the probability of MedCap AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedCap AB's price. Additionally, you may evaluate how the addition of MedCap AB to your portfolios can decrease your overall portfolio volatility.